Publications of T. Pollmächer
All genres
Journal Article (181)
101.
Journal Article
55, pp. 1231 - 1233 (2000)
Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS. Neurology 102.
Journal Article
71, pp. 375 - 85 (2000)
Diurnal variations in lipopolysaccharide-induced sleep, sickness behavior and changes in corticosterone levels in the rat. Neuroendocrinology 103.
Journal Article
278, pp. R 947 - R 955 (2000)
Dose-dependent effects of endotoxin on human sleep. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 104.
Journal Article
917, pp. 488 - 499 (2000)
Experimental immunomodulation, sleep, and sleepiness in humans. Annals of the New York Academy of Sciences 105.
Journal Article
4, pp. 68 - 78 (2000)
Schlaf und Schläfrigkeit im Rahmen von Infektionen und im Rahmen experimenteller Immunmodulation beim Menschen. Somnologie 106.
Journal Article
72, pp. 195 - 198 (2000)
Reduced leptin levels in human narcolepsy. Neuroendocrinology 107.
Journal Article
355, pp. 1274 - 1275 (2000)
Increased body-mass index in patients with narcolepsy [Lett]. Lancet 108.
Journal Article
43, pp. 159 - 166 (2000)
Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophrenia Research 109.
Journal Article
102, pp. 153 - 155 (2000)
Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia. Acta Psychiatrica Scandinavica 110.
Journal Article
33, pp. 109 - 111 (2000)
A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry 111.
Journal Article
85, pp. 4624 - 4629 (2000)
Changes in dehydroepiandrosterone (DHEA) and DHEA-sulfate plasma levels during experimental endotoxinemia in healthy volunteers. Journal of Clinical Endocrinology & Metabolism 112.
Journal Article
23, pp. 361 - 367 (2000)
Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 113.
Journal Article
917, pp. 478 - 487 (2000)
Illness, cytokines, and depression. Annals of the New York Academy of Sciences 114.
Journal Article
141, pp. 107 - 110 (1999)
Characterization of the sigma ligand panamesine by immune response during four-weeks treatment in patients with schizophrenia and by sleep-EEG changes in normal controls. Psychopharmacology 115.
Journal Article
33, pp. 407 - 418 (1999)
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis. Journal of Psychiatric Research 116.
Journal Article
156, pp. 312 - 314 (1999)
Body weight and leptin plasma levels during treatment with antipsychotic drugs. American Journal of Psychiatry 117.
Journal Article
19, pp. 478 - 479 (1999)
Periodic leg movements and restless legs syndrome probably caused by olanzapine. Journal of Clinical Psychopharmacology 118.
Journal Article
179, pp. 1047 - 1048 (1999)
Salmonella abortus equi endotoxin does not affect leptin plasma levels in healthy humans (and reply). Journal of Infectious Diseases 119.
Journal Article
8, pp. 321 - 322 (1999)
Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder. Journal of Sleep Research 120.
Journal Article
8, pp. 321 - 322 (1999)
Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder [Lett.]. Journal of Sleep Research